Clinical Trials Directory

Trials / Completed

CompletedNCT00310934

A Stepwise Strategy Utilizing Buprenorphine and Methadone

Graded Strategy for Pharmacological Treatment of Heroin Dependence

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
96 (planned)
Sponsor
Karolinska University Hospital · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

The objective of this study is to compare optimally given methadone maintenance treatment (MMT) for heroin dependence with a novel, sequential strategy, where patients are offered buprenorphine as first line treatment, allowed dose adjustments as needed, and switched to methadone if the maximal dose of buprenorphine is insufficient.

Detailed description

The objective of this study is to compare optimally given methadone maintenance treatment (MMT) for heroin dependence with a novel, sequential strategy (STEP), where patients are offered buprenorphine as first line treatment, allowed dose adjustments as needed, and switched to methadone if the maximal dose of buprenorphine is insufficient. For this purpose, 96 subjects at two centers (Uppsala and Stockholm) are randomized to MMT or STEP and followed for 6 months. Retention in treatment is the primary outcome. Secondary outcomes in completers are proportion urine samples free of illicit opiates on app. twice weekly sampling, and problem severity as measured by a semistructured interview, the Addiction Severity Index (ASI) at baseline and after 3 and 6 months.

Conditions

Interventions

TypeNameDescription
DRUGmethadone
DRUGbuprenorphine / methadone sequence
BEHAVIORALRelapse prevention
BEHAVIORALContingency management

Timeline

Start date
2005-08-01
Completion
2006-03-01
First posted
2006-04-05
Last updated
2006-10-24

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT00310934. Inclusion in this directory is not an endorsement.